LGT Fund Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
LGT Fund Management's PFE Position: Q2 2026 in Review
LGT Fund Management increased its Pfizer (PFE) stake by 6.1% in Q2 2026, buying an estimated $1.28M and bringing the position to 857,783 shares worth $20.7M. The position accounts for 0.86% of the portfolio, ranked #23.
LGT Fund Management first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $22.7M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- LGT Fund Management held 857,783 shares of Pfizer worth $20.7M as of Q2 2026.
- LGT Fund Management bought 48,979 Pfizer shares in Q2 2026, an estimated $1.28M.
- Pfizer made up 0.86% of LGT Fund Management's portfolio in Q2 2026, its #23 holding.
- LGT Fund Management first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
- LGT Fund Management's Pfizer position peaked at $22.7M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.